NEW YORK, NY / ACCESS Newswire / February 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of GeneDx ...

GeneDx CEO Katherine Stueland likes the potential of newborn testing, but she says her Stamford, Connecticut, company is still studying the idea. A potential challenge: Insurers would have to embrace ...

A little-known stock started to make a huge name for itself in 2024. That stock is GeneDX WGS. Through the course of 2024, this healthcare company increased its market capitalization from under $ ...